ArticleCell cycle (Georgetown, Tex.)2018

AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor.

Xiaoyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.